---
title: "Trazodone Hair and Skin Changes: What Patients and Clinicians Need to Know"
description: "A guide to trazodone's documented effects on hair and skin, including alopecia reports, dermatologic reactions, and how to manage them in practice."
url: https://healthrx.com/trazodone-v2/hair-skin-impact
publisher: HealthRX.com
---


HealthRX.com

Alopecia is listed on trazodone's label, but its rate is unknown

[Print or save as PDF](https://healthrx.com/printables/trazodone-v2/hair-skin-impact?print=1)

From the public record

Hair loss and rash terms on trazodone FDA reports, set against all medicines

Alopecia, the hair loss term this page asks about, is named on 1,592 trazodone reports, behind rash (2,594) and pruritus (2,404). The 9,066 reports naming any hair or skin term are 8.7% of the 104,704 for trazodone, against 7.6% across all medicines.

Hair loss and rash terms on trazodone FDA reports, set against all medicines: the figures

| Measure | Value | Note |
| --- | --- | --- |
| Reports naming at least one hair or skin term | 9,066 |  |
| Share of all reports for trazodone | 8.7% | of 104,704 reports |
| Same terms across every medicine in FAERS | 7.6% | share of all reports in the database, for context |
| Rash | 2,594 reports |  |
| Pruritus | 2,404 reports |  |
| Alopecia | 1,592 reports |  |
| Hyperhidrosis | 1,218 reports |  |
| Erythema | 1,010 reports |  |

Source: [FDA Adverse Event Reporting System (FAERS) via openFDA](https://open.fda.gov/data/faers/), data as of Oct 28, 2026

How this was calculated

Trazodone reports were checked for any of 23 reaction terms about hair and skin, then each term was counted on its own. A report naming both alopecia and rash is counted under each, so the term lines add up to more than the 9,066. The reports are unverified and do not establish cause.

Scope: Single-ingredient trazodone reports, any brand, naming any of 23 MedDRA hair or skin terms, up to 2026-10-28

[See the public record for Trazodone](https://healthrx.com/data/trazodone)

HealthRX.com quick answer. Yes, but rarely and without a measured rate. Trazodone's label lists alopecia (hair loss) among the skin reactions reported after the drug went to market, alongside rash, pruritus (itching), urticaria (hives), psoriasis, hirsutism (extra hair growth) and leukonychia (white nails) [1]. The label says these reports came from a population of uncertain size, so their frequency cannot be estimated and causation cannot be established [1]. When antidepressant hair loss does happen, it is usually a temporary shedding that starts about two to three months after the trigger and tends to regrow once the cause is removed [2][3].

At a glance

- Hair reaction in the label / alopecia, under postmarketing skin reactions
- Other skin reactions in the label / rash, pruritus, urticaria, psoriasis, hirsutism, leukonychia
- Skin reaction rate in controlled trials / allergic skin condition or edema 7% vs 1% with placebo (outpatients)
- Frequency of hair loss / cannot be estimated from voluntary postmarketing reports
- Typical timing of drug-related shedding / about two to three months after the trigger
- Sleep use / off-label; the label has no insomnia indication or dose
- Stopping / the label recommends gradual dose reduction rather than abrupt discontinuation

## Does trazodone cause hair loss?

Hair loss is on trazodone's label. Alopecia appears in the postmarketing section, in the list of skin and subcutaneous tissue reactions reported since approval [1]. Postmarketing means the reaction was reported voluntarily after the drug was approved, not counted in the trials that led to approval. The label says these reports come from a population of uncertain size, so it is not always possible to estimate how often they happen or to establish that the drug caused the event [1].

So alopecia is a labeled possibility, not a measured rate. Alopecia appears only in the postmarketing list, not in the controlled-trial tables where side effects were counted with percentages [1].

A review of hair loss in psychiatric medicines names trazodone directly. It reports that tricyclic antidepressants, maprotiline, trazodone and virtually all newer antidepressants may on rare occasions lead to alopecia, and that stopping the medicine or lowering the dose almost always led to complete regrowth [2]. That review gives much higher rates for other drug classes (lithium 12 to 19% of long-term users, valproate up to 12%), which puts the trazodone risk in context: hair loss is described as happening on rare occasions with trazodone [2].

Questions worth asking

Choose the questions you want to keep Is my hair loss more likely from trazodone or from something else? Could my hair shedding or skin rash be linked to trazodone, and how would we check? Should I stop trazodone if I notice hair loss, or would you lower the dose first? How would you taper me off trazodone if I need to stop? Would blood tests for iron or ferritin help figure out my hair loss? What other medicines I take could also cause hair thinning or skin reactions?

## What drug-related hair shedding looks like

The usual pattern with medicines is telogen effluvium, a diffuse, non-scarring shedding caused by a temporary disruption of the normal hair growth cycle [3][4]. Drugs, illness, surgery, childbirth, nutritional deficiency and emotional stress are all recognized triggers, and a cause cannot always be found [3][4].

| Feature | What the sources describe |
| --- | --- |
| Pattern | Diffuse, non-scarring shedding [4] |
| Timing | Hair loss generally occurs two to three months after the trigger exposure [3] |
| Acute versus chronic | Acute means shedding for less than six months; chronic means more than six months [3] |
| Outlook | Acute telogen effluvium usually goes into remission, in around 95% of cases [3] |
| Cause unknown | In around 33% of cases the cause remains unknown [3] |
| Antidepressants | Antidepressants are among the drug classes that can cause telogen effluvium [3] |

The timing matters for a reader trying to connect hair loss to a medicine. Shedding that starts about two to three months after a trigger fits the pattern, and changes in the dosage of drugs are among the reported triggers [3]. Timing alone does not prove or rule out a drug cause, and the label cannot confirm that trazodone caused any individual case [1].

## Which skin reactions does the label list?

The postmarketing entry for skin and subcutaneous tissue disorders reads: alopecia, hirsutism, leukonychia, pruritus, psoriasis, rash, urticaria [1].

Two of those are easy to overlook in a page about hair loss. Hirsutism is excess hair growth, and leukonychia is whitening of the nails. Both are listed reactions, not simply the absence of hair.

## How common are skin reactions in the controlled trials?

The trials counted a broader category than rash: "allergic skin condition/edema." In the outpatient major depression studies it occurred in 7% of people taking trazodone (n=157) versus 1% on placebo (n=158). In the inpatient studies the figures were 3% (n=142) versus 1% (n=95) [1].

That category bundles allergic skin reactions together with edema, so it is not a rash rate, and it is not a hair-loss rate. Alopecia was not among the adverse events counted in those tables [1].

## Do other antidepressants cause hair loss?

A large US health-claims cohort did not include trazodone. Etminan and colleagues followed 1,025,140 new users of ten antidepressants from 2006 to 2014 (fluoxetine, fluvoxamine, sertraline, citalopram, escitalopram, paroxetine, duloxetine, venlafaxine, desvenlafaxine and bupropion) until a first diagnosis of alopecia [5]. Compared with bupropion, every other antidepressant had a lower risk of hair loss, with fluoxetine and paroxetine lowest (hazard ratio 0.68 for each) [5]. Put the other way around, bupropion carried the highest risk relative to fluoxetine (HR 1.46, 95% CI 1.35 to 1.58; number needed to harm 242 over two years) [5].

Because trazodone was not one of the ten drugs, this cohort says nothing about its own risk.

## Other causes to rule out first

Because telogen effluvium has many triggers, hair thinning in someone who takes trazodone has several competing explanations.

| Possible cause | What the sources say |
| --- | --- |
| Thyroid disease | Both overactive and underactive thyroid can cause telogen effluvium, and it reverses once thyroid levels are normal [3] |
| Low iron stores | In a survey of 5,110 women, low ferritin was more common among those with excessive hair loss [6] |
| Other medicines | Retinoids, beta-blockers, ACE inhibitors, anticonvulsants, anticoagulants, oral contraceptives and androgens are listed drug triggers [3] |
| Illness, surgery, childbirth, emotional stress | Recognized triggers [3][4] |
| Pattern hair loss | Androgenetic alopecia is driven by dihydrotestosterone and is a different condition from shedding [7] |

## What to do if hair is thinning on trazodone

1. Do not stop trazodone on your own. The label recommends gradual dose reduction because adverse reactions can occur on discontinuation [1].
2. Write down when the thinning started and when trazodone was started or changed. The two-to-three-month window in the table above is the useful comparison [3].
3. Ask the prescriber about other triggers on the list above, including thyroid tests and [ferritin](https://healthrx.com/labs-ferritin/what-it-measures), since both are reversible causes [3][6].
4. Ask whether a lower dose or a different medicine fits, because in the psychopharmacology review reducing the dose or stopping the drug almost always led to full regrowth [2].
5. For a rash, hives or itching, tell the prescriber, since these are separate reactions on the same label list [1].

Reviews of shedding describe management as identifying triggers, educating and reassuring the patient, and offering supportive therapies when appropriate [4]. Shedding that lasts more than six months is classed as chronic, and the longer it lasts, the more likely it is that several triggers are involved, such as nutritional deficiencies, thyroid disease or other illness [3]. That is a reason to have a clinician review the full list.

## What about trazodone for sleep?

The label covers one indication, major depressive disorder in adults, and gives no insomnia dose [1]. Sleep use is off-label. Mendelson's 2005 review identified 18 studies of [trazodone for insomnia](https://healthrx.com/trazodone/off-label-uses) and concluded that the evidence for efficacy was very limited, since most studies were small, done in depressed patients, and often lacked objective sleep measures [8]. The review also noted a high incidence of discontinuation because of sedation, dizziness and psychomotor impairment [8].

## Discontinuation reactions and gradual dose reduction

The label says that adverse reactions may occur when trazodone is discontinued, and recommends gradually reducing the dose rather than stopping abruptly [1]. The discontinuation list in the label includes nausea, sweating, irritability, agitation, dizziness, electric-shock sensations, anxiety, confusion, headache, insomnia, tinnitus and seizures [1].

## Iron, minoxidil and other hair-loss treatments

Two approaches often come up for hair loss in general.

Iron: Deloche and colleagues surveyed 5,110 non-menopausal women aged 35 to 60 and measured serum ferritin in each [6]. Among women with excessive hair loss, 59% had low iron stores (ferritin below 40 micrograms/L) compared with 48% of the rest of the population, and low iron stores emerged as a risk factor for hair loss in this group [6]. That finding concerns hair loss in general, not drug-related shedding.

[Minoxidil](https://healthrx.com/products/minoxidil-finasteride-topical): a 2017 systematic review and meta-analysis of randomized trials found that low-level laser therapy, 2% and 5% minoxidil and 1 mg finasteride each beat placebo for androgenetic alopecia in men, and that 2% minoxidil beat placebo in women [7]. Androgenetic alopecia is pattern hair loss driven by dihydrotestosterone, a different problem from a shedding episode tied to a medication.

Check what you know

Think you have it? Try 5 quick questions and see what the article says.

1. According to the label, under which heading does alopecia (hair loss) appear?

Question 1 of 5

Score: 0 right, 0 of 5 answered

Printable side-effect diary

Trazodone hair and skin change diary for your visit

Use this sheet if you take trazodone and notice hair loss, extra hair, nail changes, itching, rash or hives. Record each change by hand, then bring it to your prescriber or pharmacist to discuss.

[Open the fill-in sheet](https://healthrx.com/printables/trazodone-v2/hair-skin-impact) Fill it in, print it or save it as a PDF. No sign-up.

Frequently asked questions

Does trazodone cause hair loss?

Trazodone's label lists alopecia among the skin and subcutaneous tissue reactions reported after approval [1]. Those reports are voluntary and come from a population of uncertain size, so the label cannot give a rate or confirm that trazodone caused any individual case [1]. Alopecia does not appear in the controlled-trial tables, where side effects were counted with percentages [1]. A psychopharmacology review calls hair loss with trazodone a rare occurrence that almost always regrows after the dose is lowered or the drug is stopped [2].

How long after starting trazodone would hair loss show up?

Drug-related shedding (telogen effluvium) generally begins two to three months after the trigger exposure [3]. Acute shedding lasts less than six months and usually goes into remission [3].

Which skin reactions are listed for trazodone?

Alopecia, hirsutism, leukonychia, pruritus, psoriasis, rash and urticaria, all under postmarketing skin and subcutaneous tissue disorders [1]. In the outpatient depression trials, allergic skin condition or edema occurred in 7% of people taking trazodone versus 1% on placebo [1].

What does the label say about stopping trazodone?

The label says adverse reactions may occur on discontinuation and recommends gradual dose reduction rather than abrupt discontinuation [1].

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

Does trazodone affect your skin?

Yes, according to the label. Skin reactions are listed from reports after the drug went to market: alopecia, hirsutism, leukonychia, pruritus, psoriasis, rash and urticaria. The label says these reports came from a population of uncertain size, so their frequency cannot be estimated and causation cannot be established.

Can trazodone cause hair shedding?

Hair loss is listed but not measured. Alopecia (hair loss) appears only in the postmarketing reports, which were voluntary and came from a population of uncertain size. The label cannot estimate how often it happens or confirm that trazodone caused a given case, and alopecia is not in the controlled-trial side effect tables. A review of hair loss in psychiatric medicines describes it as happening on rare occasions with trazodone, and says it almost always regrows after the dose is lowered or the drug is stopped.

How do you know if your hair is falling out from medication?

Drug-related shedding is usually telogen effluvium, which generally begins two to three months after the trigger exposure. Thyroid disease, low iron stores and other medicines are causes to rule out first. Pattern hair loss, driven by dihydrotestosterone, is a different problem from a shedding episode tied to a medication. The label cannot establish that trazodone caused any individual case of hair loss.

References

Show all 8 references Hide references

1. U.S. National Library of Medicine, DailyMed. Trazodone hydrochloride tablets (Oxford Pharmaceuticals) prescribing information. [Trazodone hydrochloride tablets (Oxford Pharmaceuticals) label](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=283c8236-9776-44cb-b7b2-1024689de736)
2. Mercke Y, Sheng H, Khan T, Lippmann S. [Hair loss in psychopharmacology](https://pubmed.ncbi.nlm.nih.gov/10798824/). Ann Clin Psychiatry. 2000;12(1):35-42.
3. Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R. Telogen effluvium: a review of the literature. Cureus. 2020;12(5):e8320. [Telogen Effluvium: A Review of the Literature](https://pubmed.ncbi.nlm.nih.gov/32607303/)
4. Bergfeld WF, Mendez D. Shedding: an updated guide to a common cause of hair loss. Cleve Clin J Med. 2026;93(10):616-622. [Shedding: An updated guide to a common cause of hair loss](https://pubmed.ncbi.nlm.nih.gov/42823125/)
5. Etminan M, Sodhi M, Procyshyn RM, Guo M, Carleton BC. [Risk of hair loss with different antidepressants: a comparative retrospective cohort study](https://pubmed.ncbi.nlm.nih.gov/28763345/). Int Clin Psychopharmacol. 2018;33(1):44-48.
6. Deloche C, Bastien P, Chadoutaud S, Galan P, Bertrais S, Hercberg S, et al. [Low iron stores: a risk factor for excessive hair loss in non-menopausal women](https://pubmed.ncbi.nlm.nih.gov/17951130/). Eur J Dermatol. 2007;17(6):507-12.
7. Adil A, Godwin M. [The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis](https://pubmed.ncbi.nlm.nih.gov/28396101/). J Am Acad Dermatol. 2017;77(1):136-141.e5.
8. Mendelson WB. [A review of the evidence for the efficacy and safety of trazodone in insomnia](https://pubmed.ncbi.nlm.nih.gov/15816789/). J Clin Psychiatry. 2005;66(4):469-76.

Next in this cluster

Related reading

- [trazodone Can you take trazodone with progesterone HRT](https://healthrx.com/interactions-trazodone/with-hrt-progesterone)
- [trazodone Trazodone and acetaminophen interaction](https://healthrx.com/interactions-trazodone/with-acetaminophen)
- [trazodone Trazodone pharmacokinetics bariatric](https://healthrx.com/trazodone/post-bariatric-considerations)
- [trazodone Trazodone for sexual function](https://healthrx.com/womens-sexual-health/trazodone-for-sexual-function)
- [lemborexant Dayvigo alcohol](https://healthrx.com/lifestyle-lemborexant/alcohol)
- [menopause related weight gain Cannabis menopause weight](https://healthrx.com/lifestyle-menopause-weight-gain/alcohol-and-substances)
- [menopause related weight gain Menopause weight gain](https://healthrx.com/lifestyle-menopause-weight-gain/nutrition-protocol)
- [menopause related weight gain Menopause weight gain Self-Monitoring](https://healthrx.com/lifestyle-menopause-weight-gain/self-monitoring)
- [menopause related weight gain Menopause weight gain sleep](https://healthrx.com/lifestyle-menopause-weight-gain/sleep-optimization)
- [menopause related weight gain Stress weight gain menopause](https://healthrx.com/lifestyle-menopause-weight-gain/stress-and-hpa)
- [menopause related weight gain Menopause weight gain supplements](https://healthrx.com/lifestyle-menopause-weight-gain/supplements)
- [trazodone Trazodone pre-surgery hold window](https://healthrx.com/trazodone-v2/pre-surgery-window)
- [trazodone Trazodone and metformin interaction](https://healthrx.com/interactions-trazodone/with-metformin)
- [methimazole Methimazole hair loss](https://healthrx.com/methimazole/hair-skin-impact)

![trazodone hair and skin changes: woman checking her scalp and hair in a vanity mirror](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/trazodone-v2/hair-skin-impact.webp)

Noticing changes in hair or skin early helps patients bring accurate details to a conversation with their clinician. Full trazodone hair loss guide and sources at [healthrx.com/trazodone](https://healthrx.com/trazodone).
